CCO Oregon’s Pharmacy workgroup is currently discussing aligned preferred drug list (PDL) proposals, pharmacist prescribing, medication therapy management, and other policies and rules that impact pharmacy costs and operations across coordinated care. While this is an independent group, the conversations are strategically aligned with the Oregon Health Authority’s ACE-P Committee, Pharmacy & Therapeutics Committee, and other related committees.
Key workgroup products include:
-
- March 2019 comment to the Health Evidence Review Commission regarding fibromyalgia and opioid therapies
- January 2019 comment to the Oregon Health Authority in response to the draft RFA aligned PDL language
- September 2018 comment to the Oregon Health Policy Board with concerns regarding an aligned PDL
- December 2017 white paper on a single/aligned preferred drug list (in partnership with COHO)
- October 2016 comment to the P&T Committee on DAA therapy for Hepatitis C
Workgroup Co-Chairs
Amy Burns, AllCare Health CCO
Robin Traver, Umpqua Health Alliance
Attending Organizations
AllCare Health CCO
CareOregon
Cascade Health Alliance
Central City Concern
InterCommunity Health Network CCO
Kaiser Permanente
Moda/Eastern Oregon CCO
PacificSource
Trillium Community Health Plan
Tuality Health Alliance
Umpqua Health Alliance
Willamette Valley Community Health CCO
Please contact Samantha to get involved.